Cost analysis and quality of life assessment comparing patients undergoing autologous peripheral blood stem cell transplantation or autologous bone marrow transplantation for refractory or relapsed non-Hodgkin's lymphoma or Hodgkin's disease - a prospective randomised trial

By van Agthoven M.   Vellenga E.   Fibbe W.E.   Kingma T.   Uyl-de Groot C.A.  

European Journal of Cancer, Vol. 37, Iss. 14, 2001-09 ,pp. : 1781-1789

Elsevier

Access to resources Recommend Favorite

Plerixafor in non-Hodgkin's lymphoma and multiple myeloma patients undergoing autologous stem cell transplantation

By Moreb Jan  

Oncology Reviews, Vol. 5, Iss. 1, 2011-03 ,pp. : 67-73

Springer Publishing Company

Access to resources Recommend Favorite

Epstein-Barr virus-associated lymphoproliferative disorder developed following autologous peripheral blood stem cell transplantation for relapsing Hodgkin's lymphoma

By          

Oncology Letters, Vol. 3, Iss. 6, 2012-01 ,pp. : 1203-1206

Spandidos Publications

Access to resources Recommend Favorite

Effect of cell determinant (CD)34+ cell dose on the cost and consequences of peripheral blood stem cell transplantation for non-Hodgkin's lymphoma patients in front-line therapy

By Limat S.   Woronoff-Lemsi M.-C.   Milpied N.   Chartrin I.   Ifrah N.   Deconinck E.   Gressin R.   Colombat P.   Cahn J.-Y.   Arveux P.   on behalf of The Groupe Ouest Est d'etude des Leucemies et Autres Maladies du Sang GOELAMS  

European Journal of Cancer, Vol. 36, Iss. 18, 2000-12 ,pp. : 2360-2367

Elsevier

Access to resources Recommend Favorite

Comparison of interleukin-12 with lung cancer and malignant lymphoma undergoing autologous peripheral blood stem cell transplantation

By Yoshimura Chie   Nomura Shosaku   Kanazawa Shigenori   Kuwana Midori   Yamaguchi Kazuyuki   Fukuhara Shirou  

Journal of Cancer Research and Clinical Oncology, Vol. 128, Iss. 1, 2002-01 ,pp. : 29-36

Springer Publishing Company

Access to resources Recommend Favorite